COMLEX®
Co-development with CEOLIA Pharma, a specialty pharmaceutical company in ENT area in JapanCOMLEX® OTIC SOLUTION 1.5% (Product code: ENT103)
First time in a quarter of a century that a full-scale clinical trial has been conducted in the field of otology
We jointly conducted a full-scale Phase III clinical trial in the otology field for the first clinical trial in a quarter of a century in Japan. We achieved the primary endpoint in September 2021 and obtained approval in Japan for manufacturing and marketing in March 2023.
Our co-developer, Ceolia Pharma Co., Ltd, markets this pharmaceutical.
